about
Evidence-based practices for substance use disordersThe development of acamprosate as a treatment against alcohol relapseManagement of "dual diagnosis" patients : consensus, controversies and considerationsMedication treatment of different types of alcoholism.Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings.Design of naltrexone-loaded hydrolyzable crosslinked nanoparticles.Alcoholism and suicidal behavior: a clinical overview.Client and counselor attitudes toward the use of medications for treatment of opioid dependence.The neurobiology, clinical efficacy and safety of acamprosate in the treatment of alcohol dependence.Addiction and the brain: the role of neurotransmitters in the cause and treatment of drug dependence.Effect of nonnicotine pharmacotherapy on smoking behavior.Treatment outcomes in type A and B alcohol dependence 6 months after serotonergic pharmacotherapy.The pharmacotherapy of alcohol dependence: a state of the art review.Differential phosphorylation of GluN1-MAPKs in rat brain reward circuits following long-term alcohol exposure.Is baclofen a revolutionary medication in alcohol addiction management? Review and recent updates.Topiramate for alcohol dependence.Disulfiram efficacy in the treatment of alcohol dependence: a meta-analysis.Acamprosate for the adjunctive treatment of alcohol dependence.Neurosteroid Binding Sites on the GABA(A) Receptor Complex as Novel Targets for Therapeutics to Reduce Alcohol Abuse and Dependence.Acamprosate in the treatment of alcohol dependence.Role of the serotonergic system in alcohol dependence: from animal models to clinics.Pharmacotherapy for alcohol dependence: anticraving medications for relapse prevention.Chemical toxicology: reactive intermediates and their role in pharmacology and toxicology.Pharmacotherapy for alcohol use disorder: current and emerging therapiesEffects of Beverages on Alcohol Metabolism: Potential Health Benefits and Harmful ImpactsCoffee and cigarette consumption and perceived effects in recovering alcoholics participating in Alcoholics Anonymous in Nashville, Tennessee, USADoctors' views of disulfiram and their response to relapse in alcohol-dependent patients, Free State, 2009.Management of alcohol dependence in patients with liver disease.Studies on in vitro availability, degradation, and thermal properties of naltrexone-loaded biodegradable microspheres.Alcohol Education Inventory-Revised: what every mental health professional should know about alcohol.The BRENDA model: integrating psychosocial treatment and pharmacotherapy for the treatment of alcohol use disorders.Naltrexone (50 mg) plus psychotherapy in alcohol-dependent patients: a meta-analysis of randomized controlled trials.Eosinophils in the lung - modulating apoptosis and efferocytosis in airway inflammation.Are Alcohol Anti-relapsing and Alcohol Withdrawal Drugs Useful in Cannabinoid Users?Treatment of Alcohol Use Disorder in Patients with Alcoholic Liver Disease.An extract of the Chinese herbal root kudzu reduces alcohol drinking by heavy drinkers in a naturalistic setting.Disulfiram Use in an Elderly Man With Alcoholism and Heart Disease: A Discussion.The European NEAT program: an integrated approach using acamprosate and psychosocial support for the prevention of relapse in alcohol-dependent patients with a statistical modeling of therapy success prediction.Remission of alcohol dependency following deep brain stimulation of the nucleus accumbens: valuable therapeutic implications?Remission of alcohol dependency following deep brain stimulation of the nucleus accumbens: valuable therapeutic implications?
P2860
Q24614016-4A5DABD1-E746-48EA-898D-8FBFAF320A71Q26862199-73E4E58A-0CAD-4505-9DDE-1357C45CE6EFQ30400782-C60DF827-B096-4E96-8E3E-B16F1BBDC41FQ30434793-3195DD94-8C32-4D5C-8314-E54F617BBFE1Q30440516-A001AA37-38B6-451E-968E-F014A6BE5662Q31106478-4B53C181-6FBA-4CF8-8702-A0B0851BF36AQ33230757-0F2E5EF1-B8C2-4031-A4AA-115F6E889545Q33763021-11904E38-55DE-41F9-A75D-0794FE9C3B21Q34088940-12673097-17C7-49E5-8B6A-315B11C63640Q34200260-4A220D95-5AB2-417D-BD61-A134E4AC9E61Q34476913-DB09252D-5ADF-47F6-B95E-D2BB13113CBAQ34536749-2DA600BA-3AFC-47E4-ABCF-BA61279E4862Q34543952-4C7D4729-5074-4572-A3D6-D74A2F1AD8FDQ34571443-BC74C4B1-FCD1-48B6-84AE-58D194B5B26AQ34642726-635CB7B9-E93F-4ACA-9D62-9BC8D6DBCB89Q34807706-0BF9A1A4-44A6-4307-B715-AFD3BAFA88D4Q35092623-2985863F-4D33-425E-B4E9-5779B0B20C7AQ35169452-40D1E318-CE39-4B3F-9CD0-5BA7716FE41AQ35505547-DB750676-650F-4038-B0CC-EB9FC2346298Q36273459-BF0DC935-4AB6-463F-8047-E492D9023B15Q36429331-E7425CD1-3825-4816-B8EA-B1002065C1CAQ36461774-5662BCE9-FCB8-4ECB-9B92-0FC6D1CB7C4CQ36662875-17859E4D-0EBD-4A36-B9F6-5E5CFB52C4A3Q36684437-B444B32B-6032-49DF-8A52-81592F4B55E3Q36743655-289EFFA1-AC69-4A2E-9C4C-A3EAF33A95B4Q36979706-52590D41-8A61-41E3-A6DF-B49648745ACCQ37051354-10AC0068-1FFA-404E-A02A-060496A7EBE8Q37165425-8EE68E22-7295-4E2E-8218-80F693AA67C2Q37205726-F597E945-3CF9-44EE-925B-50131FDC28E7Q37251381-B3425AE5-18DF-4FD9-8F51-24C5DD758FBAQ37392393-68263B95-B6B7-4955-B703-B06257ED7914Q38110618-79D8D6BE-CB8E-4F86-86EC-6AD5D30E53C9Q38234940-5C885FBE-93DB-4995-8834-E09CC499B593Q38916400-54AD89DA-516A-403F-9B63-4FB086168277Q39041281-EA0EA865-8AB2-4A2E-9431-3FB703E39202Q39717018-EFC4C563-17E3-4FF0-AF74-7D440F0C5086Q40621807-7C873900-84FE-49B9-8D62-F5387B88ADB4Q40625914-51227063-343E-46CA-948F-C4FB6D2112D8Q42023834-84016081-6586-4D96-BEFB-530E7FA99CBFQ42049388-977B69B9-A119-424C-94D6-660C848C905A
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Drug therapy for alcohol dependence.
@ast
Drug therapy for alcohol dependence.
@en
type
label
Drug therapy for alcohol dependence.
@ast
Drug therapy for alcohol dependence.
@en
prefLabel
Drug therapy for alcohol dependence.
@ast
Drug therapy for alcohol dependence.
@en
P1476
Drug therapy for alcohol dependence.
@en
P2093
P304
P356
10.1056/NEJM199905133401907
P407
P577
1999-05-01T00:00:00Z